K. Stgeorge et Cr. Rinaldo, COMPARISON OF COMMERCIALLY AVAILABLE ANTIBODY REAGENTS FOR THE CYTOMEGALOVIRUS PP65 ANTIGENEMIA ASSAY, Clinical and diagnostic virology, 7(3), 1997, pp. 147-152
Background: The Argene Biosoft 1C3 and the Biotest C10,C11 monoclonal
antibodies are two of the most commonly used commercially available an
tibody reagents for the cytomegalovirus (CMV) pp65 antigenemia assay.
Objectives: The sensitivities of these two reagents were compared in p
eripheral blood specimens received for CMV antigenemia testing. Study
design: A total of 1149 peripheral blood specimens were processed for
CMV antigenemia testing. Duplicate slides were stained with the Biosof
t 1C3 and Biotest C10,C11 monoclonal antibodies. Results: A total of 1
58 specimens gave a positive result by one or both antibodies. One hun
dred and forty five were positive by the Biosoft antibody and 130 were
positive by the Biotest antibody. Positive cell counts were significa
ntly higher on cell preparations stained by the Biosoft antibody (Wilc
oxon signed rank, P<0.001) and the Biosoft antibody detected twice as
many low-level positive specimens as the Biotest. Conclusions: The Bio
soft antibody reagent was superior to the Biotest reagent for the dete
ction of CMV antigenemia. This is an important factor since early dete
ction is essential for appropriate initiation of preemptive antiviral
therapy, particularly in transplant recipients at high risk of CMV dis
ease. (C) 1997 Elsevier Science B.V.